MedCity News September 13, 2024
As we confront the sobering statistics and growing impact of colorectal cancer, it’s clear that more education about the various options for testing is needed to increase screening rates across the U.S.
Results from a new JAMA Network study support the large-scale use of FIT tests. The findings show that those who complete one or more fecal immunochemical test (FIT) screenings are associated with a 33% lower risk of death from colorectal cancer.
The news is promising, given colorectal cancer (CRC) is now the leading cause of cancer deaths in men under the age of 50 and second for women under 50. However, work remains to be done.
Despite its proven effectiveness, FIT testing is still underutilized. Lack...
Today's Sponsors
Today's Sponsor